6301 - 6310 of 8808 Results
Title
Year
-
OPENTitle: Distinct alterations in Parkinson's medication-state and disease-state connectivityJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 575End Page: 585Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.09.004Best OA location URL: https://doi.org/10.1016/j.nicl.2017.09.004Citation Count: 44
-
OPENTitle: Targeted deletion ofGD3synthase protects againstMPTP‐induced neurodegenerationJournal Name: Genes, Brain and BehaviorPublisher: WileyVol: 16Issue #: 5Start Page: 522End Page: 536Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1111/gbb.12377Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/gbb.12377Citation Count: 22
-
OPENTitle: PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista JunctionsJournal Name: Molecular CellPublisher: Elsevier BVVol: 69Issue #: 5Start Page: 744End Page: 756.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2018.01.026Best OA location URL: http://www.cell.com/article/S1097276518300558/pdfCitation Count: 100
-
RESTRICTEDTitle: Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarkerJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 135Issue #:Start Page: 107854End Page: 107854Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107854Citation Count: 0
-
OPENTitle: Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 42Issue #: 3Start Page: 327End Page: 340Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.01.024Best OA location URL: https://lup.lub.lu.se/record/1831976Citation Count: 169
-
RESTRICTEDTitle: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008Citation Count: 0
-
RESTRICTEDTitle: The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 2Start Page: 273End Page: 293Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29688Citation Count: 8
-
RESTRICTEDTitle: Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”Journal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.70053Citation Count: 0
-
RESTRICTEDTitle: The meaning of a “hippo” response on the Montreal Cognitive Assessment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 4Start Page: 463End Page: 465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.09.005Citation Count: 1
-
RESTRICTEDTitle: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 39End Page: 42Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.06.019Citation Count: 1